Keller Postman LLC has been filing new claims against the makers of generic store brand acetaminophen that allege a prenatal link between acetaminophen and autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD).
Acetaminophen has long been marketed as the safest over-the-counter pain relief drug on the market for pregnant women. However, increasing experimental and epidemiological research over the course of the last decade shows that prenatal exposure to acetaminophen alters fetal development, which significantly increases the risks of neurodevelopmental disorders such as ASD and ADHD.
Partner Ashley Keller, Managing Partner Warren Postman, and Associate Ashley Barriere are leading the litigation on behalf of the firm’s clients and providing counsel to other firms filing claims. Given the strong and substantial scientific evidence, we intend to hold defendants accountable for failing in their duty to adequately warn of the hazards of prenatal exposure to acetaminophen.
Click here to read more from Law.com (subscription required).
We're ready to start fighting for you. Tell us more about your situation and a member of our team will contact you soon.
First Name
Last Name
Email Address
Phone Number
Zip Code
—Please choose an option—Acetaminophen (Tylenol)OxbrytaCamp LejeuneDepo-ProveraHair RelaxerNEC/Infant-FormulaParagardTalcum Powder3MZantacAuto Accident InjurySlip and FallAnimal Injury/AttackWork Place InjuryMedical Professional InjuryOther
Describe Your Issue
By submitting, you agree to our Terms & Privacy Policy, and you are providing express consent to receive automated communications including calls, texts, emails, and/or prerecorded messages.